A physician-scientist at the University of Arizona Cancer Center investigated a novel treatment for pancreatic …
Read More »
SAN DIEGO–(BUSINESS WIRE)–Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the …
Read More »
The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
NEW YORK–(BUSINESS WIRE)–New data show that switching patients with Crohn’s disease (CD) to INFLECTRA (infliximab …
Read More »
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that the …
Read More »
NORTH CHICAGO, Ill., Oct. 26, 2017 /PRNewswire/ — AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, …
Read More »
DURHAM, N.C.–(BUSINESS WIRE)–GeneCentric Therapeutics announced today that it will present data on the potential of …
Read More »
STAINES-UPON-THAMES, United Kingdom, Oct. 27, 2017 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today new investigational …
Read More »
SAN RAFAEL, Calif., Oct. 26, 2017 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today …
Read More »
HAMBURG, Germany–(BUSINESS WIRE)–Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and TESARO, Inc. (“TESARO”) …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »
SOUTH PLAINFIELD, N.J., Oct. 25, 2017 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced …
Read More »
WILMINGTON, Del. & ROCKVILLE, Md.–(BUSINESS WIRE)–Incyte Corporation (NASDAQ:INCY) and MacroGenics, Inc. (NASDAQ:MGNX) announced today that …
Read More »
JUPITER, Fla., Oct. 25, 2017 /PRNewswire-USNewswire/ — Scientists from the Florida campus of The Scripps …
Read More »
WASHINGTON–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a Phase 2, randomized, placebo-controlled …
Read More »
FRAMINGHAM, Mass.–(BUSINESS WIRE)–Alzheon, Inc., a clinical stage biopharmaceutical company focused on developing new medicines for …
Read More »
THOUSAND OAKS, Calif., Oct. 23, 2017 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced top-line results …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
